Abstract
It has been proposed that three major receptor subtypes subserve the putative transmitter role of glutamate and aspartate in the mammalian central nervous system. One subtype is classified by the specific agonist N-methylaspartate (NMA)1–4 and the specific antagonist 4-amino-2-phosphonovaleric acid4. It has been shown recently that excitation of neurones by NMA is also selectively reduced by dissociative anaesthetics such as ketamine and phencyclidine5,6 and by sigma opiates7, drugs of abuse with common psychotomimetic properties8,9. Responses to NMA have an unusual voltage relation10,11 which may result from a voltage-dependent block of the activated channel by physiological concentrations of magnesium12–14. No synaptic potential with properties similar to those of responses to NMA, however, has yet been reported. We describe here an excitatory postsynaptic potential (e.p.s.p.) evoked by electrical stimulation of the white matter and recorded intracellularly from pyramidal cells in slices of rat somatosensory cortex. This e.p.s.p. has the appropriate voltage relation and sensitivity to Mg2+ and ketamine to be an NMA receptor-mediated synapse and a potential central site for the psychotomimetic actions of ketamine.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Curtis, D. R. & Johnston, G. A. R. Ergbn. Physiol. 69, 97–188 (1974).
McLennan, H. & Lodge, D. Brain Res. 169, 83–90 (1979).
Davies, J. & Watkins, J. C. J. Physiol., Lond. 297, 621–635 (1979).
Watkins, J. C. & Evans, R. H. A. Rev. Pharmac. Tox. 21, 165–204 (1981).
Anis, N. A., Berry, S. C., Burton, N. R. & Lodge, D. Br. J. Pharmac. 79, 565–575 (1983).
Harrison, D. L. Simmonds, M. A. Br. J. Pharmac. (in the press).
Berry, S. C., Dawkins, S. L. & Lodge, D. Br. J. Pharmac. 83, 179–185 (1984).
Domino, E. F. & Luby, E. D. in PCP (Phencyclidine): Historical and Current Perspectives (ed. Domino, E. F.) 401–413 (NPP Books, Ann Arbor, 1981).
Jasinski, D. R. et al. PCP (Phencyclidine): Historical and Current Perspectives (ed. Domino, E. F.) 331–400 (NPP Books, Ann Arbor, 1981).
Macdonald, J. F., Porietis, A. V. & Wojtowicz, J. M. Brain Res. 237, 248–253 (1982).
Dingledine, R. J. Physiol., Lond. 343, 385–405 (1983).
Ault, B., Evans, R. H., Francis, A. A., Oakes, D. J. & Watkins, J. C. J. Physiol., Lond. 307, 413–428 (1980).
Nowak, L., Bregestovski, P., Ascher, P., Herbert, A. & Prochiantz, A. Nature 307, 462–465 (1984).
Mayer, M. L., Westbrook, G. L. & Guthrie, P. B. Nature 309, 261–263 (1984).
Scholfield, C. N. J. Physiol., Lond. 275, 535–546 (1978).
Ogawa, T., Ito, S. & Kato, H. Brain Res. 226, 315–319 (1981).
Connors, B. W., Gutnick, M. J. & Prince, D. A. J. Neurophysiol. 48, 1302–1320 (1982).
Stafstrom, C. E., Schwindt, P. C. & Crill, W. E. Brain Res. 236, 221–226 (1982).
Scholfield, C. N. J. Physiol., Lond. 275, 547–557 (1978).
Vogt, B. A. & Gorman, A. L. F. J. Neurophysiol. 48, 1257–1273 (1982).
Hicks, T. P. & Guedes, R. C. A. Expl Brain Res. 49, 157–173 (1983).
White, P. F., Way, W. L. & Trevor, A. J. Anesthesiology 56, 119–136 (1982).
Lodge, D. & Berry, S. C. in Modulation of Sensorimotor Activity During Alterations in Behavioural States (ed. Bandler, R.) 503–518 (Liss, New York, 1984).
Haas, H. L., Schaerer, B. & Vosmansky, M. J. Neurosci. Meth. 1, 323–325 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thomson, A., West, D. & Lodge, D. An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine?. Nature 313, 479–481 (1985). https://doi.org/10.1038/313479a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/313479a0
This article is cited by
-
Do Hallucinogens Have a Role in the Treatment of Addictions? A Review of the Current Literature
SN Comprehensive Clinical Medicine (2021)
-
Triple Therapeutic Effects of Ketamine in Prehospital Settings: Systematic Review
Current Emergency and Hospital Medicine Reports (2020)
-
The 1980s: d-AP5, LTP and a Decade of NMDA Receptor Discoveries
Neurochemical Research (2019)
-
Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice
Psychopharmacology (2016)
-
Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?
Neuropsychopharmacology (2015)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.